Greenleaf Medical Associates, SC is categorized under Primary Care Centers in Waukegan, IL and active since 2000.
Greenleaf Medical Associates, SC was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number by the NAICS.
If you are seeking more information, feel free to contact Dr Peter Puthenveetil MD at the company’s single location by writing to 401 S. Greenleaf Ave, Suite One, Waukegan, Illinois IL 60085 or by phoning (847) 662-0978. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Greenleaf Medical Associates, SC |
Contact Person: | Dr Peter Puthenveetil MD |
Address: | 401 S. Greenleaf Ave, Suite One, Waukegan, Illinois 60085 |
Phone Number: | (847) 662-0978 |
Website Address: | greenleafmedical.com |
Annual Revenue (USD): | Unknown |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Primary Care Centers |
Share This Business: |
Greenleaf Medical Associates, SC was started in 2000 to provide professional Primary Care Centers under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Dr Peter Puthenveetil MD for inquiries that concern Greenleaf Medical Associates, SC by calling the company number (847) 662-0978, as your correspondence is most welcome. Additionally, the physical location of the single location of Greenleaf Medical Associates, SC can be found at the coordinates 42.353656768798,-87.901 as well as the street address 401 S. Greenleaf Ave, Suite One in Waukegan, Illinois 60085.
For its online presence, you may visit Greenleaf Medical Associates, SC’s website at greenleafmedical.com and engage with its social media outlets through on Twitter and on Facebook.